Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse

Peptides

Volumn 19, Issue 5, 1998, Pages 925-929

  Champion, Hunter C ^a   Zadina, James E ^a,b   Kastin, Abba J ^a,b   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

selective peptides; Arterial pressure; Endomorphin; Naloxone; Opiates

Indexed keywords

ENDORPHIN; ENDORPHIN 1; ENDORPHIN 2; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MU OPIATE RECEPTOR AGONIST; NALOXONE; NOCICEPTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANESTHETICS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDORPHINS; FEMALE; MALE; MICE; MICE, INBRED STRAINS; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; VASODILATOR AGENTS;

EID: 0031836737     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00026-6     Document Type: Article

References (10)

1. Champion, H. C.; Zadina, J. E.; Kastin, A. J.; Kadowitz, P. J. Endomorphin 1 and 2, the endogenous ligands for the μ receptor, decrease cardiac output and total peripheral resistance in the rat. Peptides. 18:1393-1397; 1997.
2. Champion, H. C.; Zadina, J. E.; Kastin, A. J.; Hackler L.; Ge, L-J.; Kadowitz, P. J. Endomorphin 1.; 2, the endogenous μ-opioid agonists, have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235:567-570; 1997.
3. Czapla, M. A.; Champion, H. C.; Zadina, J. E.; Kastin, A. J.; Hackler, L.; Ge, L-J.; Kadowitz, P. J. Endomorphin 1 and 2, the endogenous μ-opioid agonists, possess hypotensive activity in the rat. Life Sci. 62:PL175-PL179; 1998.
4. Faden, A. I. Role of endogenous opioids in central cardiovascular regulation and dysregulation. In: Herz, A.; Akil, H.; Simon, E. J., eds. Handbook of experimental pharmacology. Berlin: Springer-Verlag; 1993:191-204.
5. Feuerstein, G.; Siren, A. L. The opioid system in cardiac and vascular regulation of normal and hypertensive states. Circulation. 75:I125-I129; 1987.
6. Hackler, L.; Zadina, J. E.; Ge, L-J.; Kastin, A. J. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides. 18:1635-1638; 1997.
7. Holaday, J. W. Cardiovascular effects of endogenous opiate systems. Ann. Rev. Pharmacol. 23:541-594; 1983.
8. Johnson, M. W.; Mitch, W. E.; Wilcox, C. S. The cardiovascular actions of morphine and the endogenous opioid peptides. Prog. Cardiovasc. Dis. 27:435-450; 1985.
9. Julius, D. Another opiate for the masses? Nature (London). 386:442; 1997.
10. Zadina, J. E.; Hackler, L.; Ge, L-J.; Kastin, A. J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature (London). 386:499-502; 1997.